Bionano Genomics, Inc.
BNGO
$1.18
-$0.02-1.67%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 10.60% | -4.66% | 6.71% | -24.04% | -121.02% |
| Total Depreciation and Amortization | -0.59% | -1.13% | -1.61% | -0.16% | -2.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 24.33% | -22.69% | -5.31% | -31.33% | 140.79% |
| Change in Net Operating Assets | -4.45% | -338.26% | 126.14% | -32.37% | -137.72% |
| Cash from Operations | 18.30% | -36.91% | 29.46% | -69.74% | -26.16% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 150.71% | 36.12% | 185.86% | -335.93% | 114.07% |
| Cash from Investing | 150.71% | 36.12% | 185.86% | -335.93% | 114.07% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -51,335.00% | -11.11% | 99.05% | -24.77% | -0.13% |
| Issuance of Common Stock | -12.06% | -59.74% | -86.47% | 318.60% | -76.80% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 7.14% | 78.46% | 86.58% | -831.73% | 88.68% |
| Cash from Financing | -1,575.34% | -59.01% | -84.09% | 585.91% | -86.51% |
| Foreign Exchange rate Adjustments | -80.00% | -28.57% | -53.33% | 162.50% | -166.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -268.98% | -72.09% | 390.54% | -688.89% | 98.94% |